Health science biotechnology employment is concentrated in
the core metropolitan areas of the state. It appears that the metropolitan
areas of St. Louis (City and County) and St. Joseph (Buchanan County) have
high specialization in biotechnology employment.
Several rural counties also show high specialization in
health science biotech employment. It was found that Audrain (Mexico), Henry
(Clinton), Howard (Fayette), and Maries (Belle) counties all had
unexpectedly high SRs. However, in nominal terms biotech employment was
overwhelmingly concentrated in the urban areas of the state.
In 1999, the health science biotechnology sector directly
accounted for 1.05% of total GSP in Missouri ($1.60 billion). Indirect and
induced economic effects attributable to this sector accounted for 1.01% of
GSP ($1.55 billion). Taken together, the health science biotech sector
directly and indirectly accounted for 2.07% of total GSP in Missouri ($3.15
billion).
In 1999, there were 11,170 health science biotechnology
sector jobs in Missouri, with an average wage of $74,014. This direct
employment created an additional 32,736 ancillary jobs in the Missouri
economy for a total impact of 43,906 jobs statewide.
The creation of 100 jobs in the health science biotech
sector would produce $7,401,378 in wages statewide, resulting in an average
wage per job of $74,013. This direct impact would also create an additional
293 ancillary jobs and $7,638,102 in wages, for a total impact of 393 jobs
and $15,039,480 in wages across Missouri.
The creation of new health science biotechnology jobs in
the state has positive long-term employment and wage impacts. In 2000, the
creation of 100 biotech jobs would result in 510 additional jobs with a
total payroll of $18.5 million. The effect of this impact would decrease by
2005, resulting in 404 additional jobs with a total payroll of $17.05
million. By 2010 there is some recovery, with the impact resulting in 440
additional jobs with a payroll of $15.90 million.
In 2000, the creation of 100 new biotech jobs would result
in $764,000 in additional general sales tax revenues, $469,200 in additional
individual income tax revenues, $141,200 in additional corporate income tax
revenues, and $91,910 in additional motor fuel sales tax revenues. However,
state tax revenue impacts attributable to the creation of 100 new biotech
jobs decrease moderately by 2010.
